Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Rundfeldt

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Veterinary Record|June 25, 2016
Quality of life of dogs with chronic epilepsyChris Rundfeldt
CNS Drugs|December 21, 2013
The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsyChris Rundfeldt, Wolfgang Löscher
Pharmacology, Biochemistry, and Behavior|January 30, 2007
ELB139 an agonist at the benzodiazepine binding site increases 5-HT in the striatum and prefrontal cortex of rats: a microdialysis studyBarbara Langen, Chris Rundfeldt
BMC Veterinary Research|September 3, 2015
Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow upChris Rundfeldt, Andrea Tipold, Wolfgang Löscher
Veterinary Journal (London, England : 1997)|May 21, 2005
Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot studySusanne Rieck, Chris Rundfeldt, Andrea Tipold
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), in human cell preparationsRegina Draheim, Ute Egerland, Chris Rundfeldt
Journal of Neural Transmission (Vienna, Austria : 1996)|October 23, 2010
The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosisChris Rundfeldt, Katarzyna Socała, Piotr Wlaź
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
RetigabineRoger J Porter, Virinder Nohria, Chris Rundfeldt
Pharmacological Reports : PR|May 29, 2010
Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in ratsDorota Nieoczym, Katarzyna Socała, Chris Rundfeldt, et al.
Pharmacological Reports : PR|May 29, 2010
Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure modelsKatarzyna Socała, Dorota Nieoczym, Chris Rundfeldt, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Veterinary Record|June 25, 2016
Quality of life of dogs with chronic epilepsyChris Rundfeldt
CNS Drugs|December 21, 2013
The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsyChris Rundfeldt, Wolfgang Löscher
Pharmacology, Biochemistry, and Behavior|January 30, 2007
ELB139 an agonist at the benzodiazepine binding site increases 5-HT in the striatum and prefrontal cortex of rats: a microdialysis studyBarbara Langen, Chris Rundfeldt
BMC Veterinary Research|September 3, 2015
Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow upChris Rundfeldt, Andrea Tipold, Wolfgang Löscher
Veterinary Journal (London, England : 1997)|May 21, 2005
Anticonvulsant activity and tolerance of ELB138 in dogs with epilepsy: a clinical pilot studySusanne Rieck, Chris Rundfeldt, Andrea Tipold
The Journal of Pharmacology and Experimental Therapeutics|November 12, 2003
Anti-inflammatory potential of the selective phosphodiesterase 4 inhibitor N-(3,5-dichloro-pyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic acid amide (AWD 12-281), in human cell preparationsRegina Draheim, Ute Egerland, Chris Rundfeldt
Journal of Neural Transmission (Vienna, Austria : 1996)|October 23, 2010
The atypical anxiolytic drug, tofisopam, selectively blocks phosphodiesterase isoenzymes and is active in the mouse model of negative symptoms of psychosisChris Rundfeldt, Katarzyna Socała, Piotr Wlaź
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
RetigabineRoger J Porter, Virinder Nohria, Chris Rundfeldt
Pharmacological Reports : PR|May 29, 2010
Effects of sildenafil on pentylenetetrazol-induced convulsions in mice and amygdala-kindled seizures in ratsDorota Nieoczym, Katarzyna Socała, Chris Rundfeldt, et al.
Pharmacological Reports : PR|May 29, 2010
Effects of sarcosine, a glycine transporter type 1 inhibitor, in two mouse seizure modelsKatarzyna Socała, Dorota Nieoczym, Chris Rundfeldt, et al.
Pageof 4